Canada markets closed

Relmada Therapeutics, Inc. (RLMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.5300-0.2700 (-7.11%)
At close: 04:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts5555
Avg. Estimate-0.81-0.76-2.92-2.36
Low Estimate-0.87-0.9-3.22-4.12
High Estimate-0.75-0.61-2.61-1.6
Year Ago EPS-0.84-0.73-3.28-2.92
Revenue EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts5555
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History2023-06-292023-09-292023-12-302024-03-30
EPS Est.-0.9-0.91-0.83-0.85
EPS Actual-0.84-0.73-0.84-0.72
Difference0.060.18-0.010.13
Surprise %6.70%19.80%-1.20%15.30%
EPS TrendCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.81-0.76-2.92-2.36
7 Days Ago-0.88-0.75-3.06-2.36
30 Days Ago-0.88-0.75-3.06-2.36
60 Days Ago-0.78-0.67-2.64-2.61
90 Days Ago-0.78-0.67-2.64-2.61
EPS RevisionsCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days322N/A
Up Last 30 Days322N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A11N/A
Growth EstimatesRLMDIndustrySector(s)S&P 500
Current Qtr.3.60%N/AN/AN/A
Next Qtr.-4.10%N/AN/AN/A
Current Year11.00%N/AN/AN/A
Next Year19.20%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A